Stay updated with breaking news from Harvard Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The blood pressure transducers market will be driven by factors such as the increasing incidence of hypertension coupled with the geriatric...
Dublin, June 22, 2022 (GLOBE NEWSWIRE) -- The "Global Perfusion System Market (2022-2027) by Component, Type, Technique, Geography, Competitive Analysis,...
Market Size – USD 2.66 Billion in 2020, Market Growth – at a CAGR of 5.8%, Market Trend –Rising focus on drug design
Harvard Bioscience (NASDAQ:HBIO – Get Rating) was downgraded by equities research analysts at TheStreet from a “c” rating to a “d+” rating in a research note issued to investors on Monday, TheStreetRatingsTable reports. Several other equities research analysts also recently issued reports on the stock. StockNews.com started coverage on shares of Harvard Bioscience in a […]
Wall Street brokerages forecast that Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) will post $0.03 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Harvard Bioscience’s earnings. Harvard Bioscience reported earnings per share of $0.06 in the same quarter last year, which indicates a negative […]